Lexington Biosciences Inc. (LXGTF)

[LittleBlondie]

ABOUNDANCE IS HERE: Multi-Billion Dollar Global Medical Device Industry Led By Cardiovascular Monitoring Devices

Global revenues for the medical device market are already a multi-billion dollar industry and the sector aims to continue its growth through leverage created through mergers and acquisitions, as well as the development of new products with improved efficiency. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as spine disorders, diabetes, and cardiovascular diseases, are expected to drive the market growth. In terms of application, the cardiovascular segment is expected to register the highest CAGR. The medical device sector as a whole has long been one of the more lucrative markets in the overall healthcare industry, as technology and research have propelled the market to new heights. With the rising influence of technology, the players in the medical device market are constantly diversifying and include some big tech names as of late. Active healthcare companies today with current developments include: Lexington Biosciences, Inc. (CNSX:LNB.CN) (OTC:LXGTF), Immunomedics Inc. (NASDAQ:IMMU), Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), BioTelemetry Inc. (NASDAQ:BEAT), VistaGen Therapeutics Inc. (NASDAQ:VTGN).